Relay Therapeutics, Inc.: accounts_payable
| Value | {"amount": 7973000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2024-03-31) |
| Status | current |
| Entity | Relay Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:14:39.378863+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/cb8bf44f-54e1-4013-8037-62900dbe5610
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-24-052135Retrieved: 2026-08-19T18:14:39.378863+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001812364/accounts-payable/2024-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/cb8bf44f-54e1-4013-8037-62900dbe5610
History
- no predecessors — first report